Trials / Completed
CompletedNCT03687346
Biological Risk Factors for Onset of Binge Eating and Compensatory Behaviors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- Oregon Research Institute · Academic / Other
- Sex
- Female
- Age
- 13 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this proposed project is to test whether several biological factors (such as elevated brain reward region and attention region response to high-calorie foods, weaker inhibitory region response to high-calorie foods, habitual caloric deprivation, and elevated limbic region responsivity) increase the risk of problematic eating (bingeing and purging) in female adolescents.
Detailed description
Participants will be adolescent girls aged 13-16, some of whom will have parental history of eating pathology. Participants will be recruited from the general population but their age, gender, and the presence of parental lifetime eating pathology will create a high-risk sample. The goals of the proposed project are to (1) conduct a prospective high-risk study to test whether proposed biological risk factors predict the future onset of core ED symptoms (e.g., binge eating, compensatory behaviors); (2) test hypotheses regarding how these biological risk factors and established self-report ED risk factors may work together to predict ED behavior onset; (3) examine if certain biological factors account for the effects of certain established self-reported ED risk factors (e.g., elevated brain response to thin models accounts for the effect of questionnaire-measured thin-ideal internalization). The participants will complete a baseline assessment and then follow-ups assessments over a span of three years. In addition, participants will complete one fMRI scan after the first assessment. During the COVID-19 shelter-at-home order, the investigators will not measure in person only outcomes including fMRI scans, height and weight measurement for BMI calculation nor IAT computer paradigms for all participants that have assessments due during this order.
Conditions
Timeline
- Start date
- 2017-08-03
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2018-09-27
- Last updated
- 2021-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03687346. Inclusion in this directory is not an endorsement.